Selegiline Hydrochloride
- Product NDC
- 71335-2676
- 11-digit product format
- 713352676
- Labeler code
- 71335
- Product ID
- 71335-2676_c3d9a9b2-d6f7-4008-9fa8-e198f1f5bbbb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Selegiline Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA075352
- Marketing category
- ANDA
- Marketing start
- 2021-04-01
- Substance
- SELEGILINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 6W731X367Q | SELEGILINE HYDROCHLORIDE | 14611-52-0 | SELEGILINE HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-2676-1 | 71335267601 | 30 CAPSULE in 1 BOTTLE (71335-2676-1) | 30 capsule | 2025-08-18 | No | No | Historical |